New Insights Into Immunological Therapy for Retinal Disorders

Area of Science:

• Ophthalmology
• Immunology
• Biomedicine

Background:

• Effective treatments for retinal disorders were limited in the 20th century.
• Advances in biomedicine have introduced new strategies targeting vascular endothelial growth factor and tumor necrosis factor (TNF)-α.
• Gene therapy trials have begun for specific forms of retinitis pigmentosa (RP).

Purpose of the Study:

• To review immunological mechanisms in normal eyes and retinal disorders.
• To discuss recent studies on inflammatory responses in retinal diseases.
• To provide insights into the diagnosis and treatment of retinal disorders.

Main Methods:

• Literature review of immunological mechanisms.
• Analysis of recent studies on inflammatory responses.
• Overview of treatment strategies for retinal disorders.

Main Results:

• Biologics targeting vascular endothelial growth factor and TNF-α have emerged as new treatments.
• Improved survival rates for vitreoretinal lymphoma (VRL) due to earlier diagnosis and treatment.
• Challenges persist, including non-response to therapies and limited treatments for RP.

Conclusions:

• Understanding ocular immunology is crucial for diagnosing and treating retinal diseases.
• New biologic and gene therapies show promise but require further research.
• Addressing treatment resistance and developing effective RP strategies are critical future directions.